dc.contributor.author | Golboni, F. | |
dc.contributor.author | Heydarpour, S. | |
dc.contributor.author | Taghizadeh, Z. | |
dc.contributor.author | Kazemnezhad, A. | |
dc.date.accessioned | 2014-06-17T09:45:21Z | |
dc.date.available | 2014-06-17T09:45:21Z | |
dc.date.issued | 2011 | EN |
dc.identifier.issn | 1020-3397 | EN |
dc.identifier.other | http://applications.emro.who.int/emhj/V17/10/17_10_2011_0744_0748.pdf | EN |
dc.identifier.uri | https://iris.who.int/handle/10665/118209 | |
dc.description | 744-748 | EN |
dc.description.abstract | While pre-eclampsia is the most common complication of pregnancy, a definitive screening test for early diagnosis is still elusive. In this study, haematocrit value was assessed as a screening test for pre-eclampsia in 660 women at 24-28 weeks of pregnancy attending a hospital in Tehran, Islamic Republic of Iran. Mean haematocrit values were significantly higher in pre-eclamptic than non-pre-eclamptic women; 37.7% [SD 2.0%] and 35.9% [SD 1.7%] respectively. The receiver operating characteristics curve showed that the most appropriate cut-off point for the haematocrit test in this sample of women was 38%; at this value the sensitivity was 58.6% and specificity was 88.9%; positive and negative predictive values were 33.7% and 95.7% respectively. The haematocrit, done as a routine screening test for anaemia at 24-28 weeks of pregnancy, may also be useful as a screening test for early diagnosis of pre-eclampsia | EN |
dc.language.iso | en | EN |
dc.subject | Pre-Eclampsia | EN |
dc.subject | Hematocrit | EN |
dc.subject | Early Diagnosis | EN |
dc.subject | Relative Value of Tests | EN |
dc.subject | Sensitivity and Specificity | EN |
dc.subject.mesh | Pre-Eclampsia | EN |
dc.title | Predictive value of plasma haematocrit level in early diagnosis of pre-eclampsia | EN |
dc.relation.ispartofjournal | EMHJ - Eastern Mediterranean Health Journal, 17 (10), 744-748, 2011 | |